Chief Commercial Officer (CCO)

Veracyte Announces That More Than 10 Afirma-Focused Studies Will Be Presented at the 2025 American Thyroid Association Annual Meeting

Veracyte to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference

In the clinic for August 28, 2025

Veracyte reports Phase 3 STAMPEDE trial finding published in Cell

Governance, Risk & Compliance (GRC) Senior Specialist

Veracyte is a global genomic diagnostics company dedicated to transforming cancer care for patients worldwide. They are seeking a Governance, Risk & Compliance (GRC) Senior Specialist to lead and support the organization’s governance, risk, and compliance initiatives, ensuring that operations align with relevant regulations and risk management frameworks.

Sign up with Google

Sign in with Google